- Home
- BDTX vs IIF Comparison
BDTX vs IIF Comparison
Compare BDTX & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | IIF |
|---|---|---|
| Founded | 2014 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.3M | 253.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDTX | IIF |
|---|---|---|
| Price | $2.69 | $26.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.17 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 45.4K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.94% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $70,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.12 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $18.95 |
| 52 Week High | $4.94 | $24.41 |
Technical Indicators
Market Signals| Indicator | BDTX | IIF |
|---|---|---|
| Relative Strength Index (RSI) | 26.47 | 41.38 |
| Support Level | $3.67 | $26.52 |
| Resistance Level | $3.90 | $27.51 |
| Average True Range (ATR) | 0.32 | 0.30 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 17.11 | 4.04 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.